UPLOAD Filing
Propanc Biopharma, Inc.
Date: Feb. 10, 2026 · CIK: 0001517681 · Accession: 0000000000-26-001374
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293147
Letter
February 10, 2026 James Nathanielsz Chief Executive Officer Propanc Biopharma, Inc. 302, 6 Butler Street Camberwell, VIC 3124 Australia Re:Propanc Biopharma, Inc. Registration Statement on Form S-1 Filed February 2, 2026 File No. 333-293147 Dear James Nathanielsz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Chase Chandler
Show Raw Text
February 10, 2026
James Nathanielsz
Chief Executive Officer
Propanc Biopharma, Inc.
302, 6 Butler Street
Camberwell, VIC 3124 Australia
Re:Propanc Biopharma, Inc.
Registration Statement on Form S-1
Filed February 2, 2026
File No. 333-293147
Dear James Nathanielsz:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Chase Chandler